SK127699A3 - 2,3-dihydrofuro[3,2-b]pyridin, preparation and application thereof in therapy - Google Patents

2,3-dihydrofuro[3,2-b]pyridin, preparation and application thereof in therapy Download PDF

Info

Publication number
SK127699A3
SK127699A3 SK1276-99A SK127699A SK127699A3 SK 127699 A3 SK127699 A3 SK 127699A3 SK 127699 A SK127699 A SK 127699A SK 127699 A3 SK127699 A3 SK 127699A3
Authority
SK
Slovakia
Prior art keywords
group
compound
carbon atoms
compounds
hydrogen atom
Prior art date
Application number
SK1276-99A
Other languages
English (en)
Slovak (sk)
Inventor
Alistair Lochead
Samir Jegham
Frederic Galli
Thierry Gallet
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of SK127699A3 publication Critical patent/SK127699A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
SK1276-99A 1997-03-20 1998-03-17 2,3-dihydrofuro[3,2-b]pyridin, preparation and application thereof in therapy SK127699A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9703395A FR2761072B1 (fr) 1997-03-20 1997-03-20 Derives de 2,3-dihydrofuro[3,2-b]pyridine, leur preparation et leur application en therapeutique
PCT/FR1998/000531 WO1998042713A1 (fr) 1997-03-20 1998-03-17 DERIVES DE 2,3-DIHYDROFURO[3,2-b]PYRIDINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE

Publications (1)

Publication Number Publication Date
SK127699A3 true SK127699A3 (en) 2000-05-16

Family

ID=9505006

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1276-99A SK127699A3 (en) 1997-03-20 1998-03-17 2,3-dihydrofuro[3,2-b]pyridin, preparation and application thereof in therapy

Country Status (22)

Country Link
US (1) US6143761A (xx)
EP (1) EP0971929A1 (xx)
JP (1) JP2001518099A (xx)
KR (1) KR20000076282A (xx)
CN (1) CN1251105A (xx)
AR (1) AR012097A1 (xx)
AU (1) AU6924298A (xx)
BG (1) BG103684A (xx)
BR (1) BR9808346A (xx)
CA (1) CA2282320A1 (xx)
CO (1) CO4940417A1 (xx)
EE (1) EE9900414A (xx)
FR (1) FR2761072B1 (xx)
HU (1) HUP0002335A3 (xx)
IL (1) IL131254A0 (xx)
NO (1) NO994527L (xx)
NZ (1) NZ337566A (xx)
PL (1) PL335759A1 (xx)
SK (1) SK127699A3 (xx)
TR (1) TR199902115T2 (xx)
WO (1) WO1998042713A1 (xx)
ZA (1) ZA982365B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2790474B1 (fr) 1999-03-05 2001-04-06 Synthelabo Derives de pyridopyranoazepines, leur preparation et leur application en therapeutique
SE9902267D0 (sv) * 1999-06-16 1999-06-16 Astra Ab New compounds
JP2005104838A (ja) * 2003-01-09 2005-04-21 Tanabe Seiyaku Co Ltd 縮合フラン化合物
US20070191815A1 (en) 2004-09-13 2007-08-16 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery
CN103977003A (zh) 2007-04-02 2014-08-13 帕金森氏病研究院 用于降低治疗的副作用的方法和组合物
AU2016211330A1 (en) 2015-01-28 2017-08-03 Chrono Therapeutics Inc. Drug delivery methods and systems
US9585867B2 (en) 2015-08-06 2017-03-07 Charles Everett Ankner Cannabinod formulation for the sedation of a human or animal
JP2020503950A (ja) 2017-01-06 2020-02-06 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 経皮薬剤送達の装置及び方法
JP7420797B2 (ja) 2018-05-29 2024-01-23 モーニングサイド ベンチャー インベストメンツ リミテッド 薬剤送達の方法及びシステム

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2156998T3 (es) * 1995-07-28 2001-08-01 Abbott Lab Compuestos de furopiridina, tienopiridina, pirrolopiridina y de pirimidina, piridazina y triazina relacionados utiles para controlar la transmision sinaptica quimica.

Also Published As

Publication number Publication date
WO1998042713A1 (fr) 1998-10-01
AU6924298A (en) 1998-10-20
CA2282320A1 (en) 1998-10-01
NO994527D0 (no) 1999-09-17
EP0971929A1 (fr) 2000-01-19
PL335759A1 (en) 2000-05-22
TR199902115T2 (xx) 2000-01-21
IL131254A0 (en) 2001-01-28
ZA982365B (en) 1998-09-23
FR2761072B1 (fr) 1999-04-23
AR012097A1 (es) 2000-09-27
EE9900414A (et) 2000-04-17
US6143761A (en) 2000-11-07
FR2761072A1 (fr) 1998-09-25
CN1251105A (zh) 2000-04-19
KR20000076282A (ko) 2000-12-26
JP2001518099A (ja) 2001-10-09
HUP0002335A3 (en) 2002-07-29
NZ337566A (en) 2000-09-29
NO994527L (no) 1999-11-18
CO4940417A1 (es) 2000-07-24
BR9808346A (pt) 2000-05-23
BG103684A (en) 2000-06-30
HUP0002335A2 (hu) 2001-05-28

Similar Documents

Publication Publication Date Title
CN107438606B (zh) [9,10-二甲氧基-3-(2-甲基丙基)-1h,2h,3h,4h,6h,7h,11bh-吡啶并-[2,1-a]异喹啉-2-基]甲醇及与其相关的化合物、组合物和方法
AU2001266559B2 (en) Diazabicyclic central nervous system active agents
CA2372063C (en) Pyridopyranoazepine derivatives, their preparation and their therapeutic application
US7897595B2 (en) Pyridoazepine derivatives
JP2012529529A (ja) ヒスタミンｈ３インバースアゴニスト及びアンタゴニスト、並びにその使用方法
CA2354606C (en) Azabicycloalkane derivatives and therapeutic uses thereof
SK127699A3 (en) 2,3-dihydrofuro[3,2-b]pyridin, preparation and application thereof in therapy
CN112457305A (zh) 含三环结构的芳香杂环化合物，及其制备方法和应用
EP0596897B1 (en) Hydroisoquinoline derivatives
EP2496579B1 (en) 1-substituted 2-azabicyclo[3.1.1]heptyl derivatives useful as nicotinic acetylcholine receptor modulators for treating neurologic disorders
WO2005007655A1 (en) Nicotine addiction reducing heteroaryl fused azapolycyclic compounds
IE903616A1 (en) Neuroprotectant Agents
JP2891543B2 (ja) ナフチリドンカルボン酸塩を製造するための方法および中間体
GB1563745A (en) Methanobenzazocine derivatives and process for preparing the same
KR20110009064A (ko) 신규의 크로멘 화합물, 이들의 제조 방법 및 이를 함유한 약제학적 조성물
SK212000A3 (en) 6-pyrrolidin-2-ylpyrindine derivatives, their preparation and application in therapy
SK17912000A3 (sk) 2-aminopyridny obsahujce kondenzovan cyklick substituenty ako inhibtory syntzy oxidu dusnatho
CZ328599A3 (cs) Deriváty 2,3-dihydrofuro[3,2-b]pyridinu, způsob jejich přípravy a jejich použití jako léčiv
MXPA99008537A (en) 2,3-DIHYDROFURO[3,2-b
JP2719063B2 (ja) 置換３−アミノキヌクリジンｐ物質拮抗剤
CA2563575C (en) Enantiomerically pure hexahydropyrrolocyclopentapyridine derivatives
JPH01250353A (ja) ９−アシルアミノ−テトラヒドロアクリジン誘導体及び該誘導体を有効成分とする記憶障害改善剤
CN117736205A (zh) 作为mc4r拮抗剂的稠环化合物、药物组合物及其在医药上的应用
CZ200030A3 (cs) Deriváty 6-pyrrolidin-2-ylpyrindinů, způsob jejich přípravy a farmaceutický prostředek, který je obsahuje
NZ299049A (en) Thienyl-piperidine-substituted 8-azabicyclo[3.2.1] octane derivatives, medicaments